Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study

Røgeberg, Ole; Bergsvik, Daniel; Clausen, Thomas

doi:10.1111/add.15739

Cited by 9 publications

(10 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…From Norway we have shown OAT to reduce the overdose burden, with one life saved from overdose death for each 100 person-years in OAT [13]. Enrollment into OAT crucially needs to be scaled-up in the United States, including access to all available OAT medications.…”

Section: Suggested Key Areas Of Prioritiesmentioning

confidence: 99%

What lessons from Norway’s experience could be applied in the United States in response to the addiction and overdose crisis?

Clausen

2022

Addiction

Self Cite

View full text Add to dashboard Cite

on opioid consumption as evidence of the health system's failure to deliver relief from suffering and pain management was set as a priority of new health policy. Just as in the United States, opioids were destigmatized and became the symbol of pain management. Contracts were signed between the French government and global pharmaceutical companies in order to increase the health-care system's capacity to provide opioids; yet no disaster followed [7]. Where American pain specialists were convinced by insurance companies and hospital administrators to champion opioids as a means of cutting costs, French doctors were able to resist the pressure thanks to more favourable institutional conditions which allowed them to mute the effects of neoliberal health-care reform and to maintain a multi-modal approach to pain treatment [8].

show abstract

Section: Suggested Key Areas Of Prioritiesmentioning

confidence: 99%

What lessons from Norway’s experience could be applied in the United States in response to the addiction and overdose crisis?

Clausen

2022

Addiction

Self Cite

View full text Add to dashboard Cite

show abstract

“…The decline in the burden of premature mortality incurred by drug-induced causes is in line with previous research, which has documented a gradual reduction in mortality rates in the Norwegian population of persons using opioids 58 and after release from prison. 35 This development is likely attributable to the propagation and increased availability of opioid agonist treatment 59 and, in the prison context, targeted efforts to reduce immediate overdose risk following release. 60…”

Section: Discussionmentioning

confidence: 99%

Mortality in women with a history of incarceration in Norway: a 20-year national cohort study

Svendsen,

Bukten,

Skardhamar

et al. 2024

International Journal of Epidemiology

View full text Add to dashboard Cite

Background Women carry a substantial burden of psychiatric, somatic and lifestyle-related morbidity in the prison context. By describing causes of death and estimating the risk and burden of mortality compared with the general population, this study investigates how mortality operates in this highly marginalized and under-researched population. Methods In this registry-based study of all women incarcerated in Norwegian prisons from 2000 to 2019 (N = 11 313), we calculated crude mortality rates, years of lost life and, by using mortality in age-matched women from the general population as a reference, age-standardized mortality ratios and years of lost life rates. Results Over a mean follow-up time of 10.7 years, at a median age of 50 years, 9% of the population had died (n = 1005). Most deaths (80%) were premature deaths from an avoidable cause. Drug-induced causes and deaths from major non-communicable diseases (NCDs) were most frequent (both 32%). Compared with women in the general population, women with a history of incarceration were more likely to die from any cause. Trends in annual age-standardized years of lost life rates suggest that the mortality burden associated with major NCDs has gradually replaced drug-induced causes. Conclusions Women with a history of incarceration die at a greater rate than their peers and largely from avoidable causes. The profile of causes contributing to the substantial burden of mortality placed on this population has changed over time and has important implications for future efforts to reduce morbidity and the risk of premature death following release from prison.

show abstract

“…The manufacturing and dissemination of illicit fentanyl, as well as other highly toxic and incredibly harmful synthetic drugs such as P2P methamphetamine, are highly profitable 48. As such, the presence of these drugs and their associated harms will not be eliminated without continued policy change related to how these drugs, those who use these drugs and their treatment are viewed in the USA (ie, legalisation, decriminalisation and medication-assisted treatment) 49–53…”

Section: Discussionmentioning

confidence: 99%

Predisposing, enabling and reinforcing factors associated with opioid addiction helping behaviour in tri-state Appalachian counties: application of the PRECEDE–PROCEED model–cross-sectional analysis

Wilkerson,

Sharma,

Davis

et al. 2023

BMJ Open

View full text Add to dashboard Cite

ObjectivesThe overdose epidemic was designated a ‘Public Health Emergency’ in the USA on 26 October 2017, bringing attention to the severity of this public health problem. The Appalachian region remains substantially impacted by the effects from years of overprescription of opioids, and subsequently opioid non-medical use and addiction. This study aims to examine the utility of the PRECEDE–PROCEED model constructs (ie, predisposing, reinforcing and enabling factors) to explain opioid addiction helping behaviour (ie, helping someone who has an opioid addiction) among members of the public living in tri-state Appalachian counties.DesignCross-sectional study.SettingRural county in the Appalachian region of the USA.ParticipantsA total of 213 participants from a retail mall in a rural Appalachian Kentucky county completed the survey. Most participants were between the ages of 18 and 30 years (n=68; 31.9%) and identified as men (n=139; 65.3%).Primary outcome measureOpioid addiction helping behaviour.ResultsThe regression model was significant (F(6, 180)=26.191, p<0.001) and explained 44.8% of the variance in opioid addiction helping behaviour (R2=0.448). Attitude towards helping someone with opioid addiction (B=0.335; p<0.001), behavioural skills (B=0.208; p=0.003), reinforcing factors (B=0.190; p=0.015) and enabling factors (B=0.195; p=0.009) were all significantly associated with opioid addiction helping behaviour.ConclusionsPRECEDE–PROCEED model constructs have utility to explain opioid addiction helping behaviour among individuals in a region greatly impacted by the overdose epidemic. This study provides an empirically tested framework for future programmes addressing helping behaviour related to opioid non-medical use.

show abstract

Opioid overdose deaths and the expansion of opioid agonist treatment: a population‐based prospective cohort study

Cited by 9 publications

References 22 publications

What lessons from Norway’s experience could be applied in the United States in response to the addiction and overdose crisis?

What lessons from Norway’s experience could be applied in the United States in response to the addiction and overdose crisis?

Mortality in women with a history of incarceration in Norway: a 20-year national cohort study

Predisposing, enabling and reinforcing factors associated with opioid addiction helping behaviour in tri-state Appalachian counties: application of the PRECEDE–PROCEED model–cross-sectional analysis

Contact Info

Product

Resources

About